Elaros has won funding from Innovate UK to further the development of its innovative digital bladder diary. The bladder diary is a hand-held device designed to help the growing number of men and women in the UK that suffer from bladder problems.
This project will place the bladder diary in specialist continence clinics and GP practices to compare the use of the diary with current practice, paper-based diaries. ‘Real world’ data will be collected which will help to fully evaluate the clinical and health economic impact of the diary.
Elaros CEO, Professor Paul O’Brien remarked, “This funding will enable Elaros and its partners, to carry-out the work that will enable the final adoption of the diary into general practice, which will reduce the unnecessary, inappropriate and very costly referrals to hospital from GPs”. The diary is registered as a Class 1 medical device and has been evaluated by NICE.
Professor O’Brien added, “Receiving funding from Innovate UK to further the development of the diary is extremely significant for the company and we are looking forward to working with our partners, Glasgow Caledonian University and the York Health Economic Forum to carry-out the work” The project will run for one year from 1st July 2019.